Mugda Medical College – Bangladesh
AUTHOR PROFILE
Google Scholar
EARLY ACADEMIC PURSUITS
Dr. Iftekhar Hossain Chowdhury embarked on his academic journey in the field of medicine by completing his undergraduate MBBS degree in 2009 from Dinajpur Medical College Hospital, Dinajpur under Rajshahi University, Bangladesh.
PROFESSIONAL ENDEAVORS
Following his undergraduate studies, Dr. Iftekhar pursued further specialization in Pharmacology. In 2023, he successfully completed his post-graduation MD (Pharmacology) from Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Currently, he serves as an Assistant Professor in the Department of Pharmacology at Mugda Medical College, Dhaka, Bangladesh.
CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER SCIENCE
Dr. Iftekhar has a special interest in drug repurposing and its toxicological implications in cancer patients. His research focuses on exploring the potential of existing drugs for new therapeutic purposes and understanding their toxicological effects, particularly in the context of cancer treatment.
IMPACT AND INFLUENCE
As a dedicated academic and researcher, Dr. Iftekhar's work has the potential to contribute significantly to the field of pharmacology and cancer therapeutics. His research findings could lead to the development of innovative treatment strategies and contribute to improving the quality of life for cancer patients.
ACADEMIC CITES
Dr. Iftekhar is a member of esteemed professional organizations, including the Bangladesh Society of Pharmacology and the International Union of Basic & Clinical Pharmacology (IUPHAR). His active participation in these organizations signifies his commitment to advancing the field of pharmacology through collaboration, knowledge sharing, and networking.
LEGACY AND FUTURE CONTRIBUTIONS
Dr. Iftekhar's dedication to academic pursuits and research in pharmacology positions him as a rising figure in the field. His contributions have the potential to shape future research directions, influence clinical practice, and contribute to the global fight against cancer.
NOTABLE PUBLICATION
Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-Cachexia in Advanced Cancer Patients: A Randomized, Double-Blind Trial. 2024
IUPHAR ECR review: Cancer-Related Anorexia-Cachexia in Cancer Patients: Pathophysiology and Treatment. 2024
Validation and Translation of Bengali Version of Functional Assessment of Anorexia Cachexia Therapy (Anorexia/Cachexia Subscale) for Measuring Cancer Related Anorexia Cachexia (CRAC) in Advanced Cancer Patients. 2023